Boehringer Ingelheim

Release Summary

Idiopathic Pulmonary Fibrosis (IPF): Boehringer Ingelheim's OFEV® ▼(nintedanib) is recommended for use in the NHS in England and Wales by the National Institute for Health and Care Excellence (NICE)

Boehringer Ingelheim